CellCept can cause certain side effects, some of which are more common than others. These side effects may be temporary, lasting a few days to weeks. However, if the side effects last longer than that ...

CellCept (mycophenolate mofetil) is a prescription drug used to prevent organ rejection following certain organ transplants. The drug comes in oral forms and as a liquid solution for injection. It’s ...

CellCept (mycophenolate mofetil) is a prescription drug used to prevent organ rejection after certain organ transplants. CellCept’s cost may depend on factors such as your dosage, whether you have ...

Boston, May 16, 2004 - Data presented today at a top U.S. transplant meeting demonstrated better patient and graft (organ) survival in liver and kidney transplant patients taking CellCept® ...

Data presented today at the International Society for Heart and Lung Transplantation (ISHLT) annual meeting strengthens the body of evidence that CellCept (mycophenolate mofetil, MMF) has unique ...

June 9, 2006 — The U.S. Food and Drug Administration (FDA) has approved orphan drug status for mycophenolate mofetil in the treatment of pemphigus vulgaris; second-generation antisense drug for the ...

The FDA is warning doctors and patients that CellCept, a drug for organ transplant patients, can cause miscarriages and birth defects. Made by Roche, CellCept will get a "black box" warning that it's ...

Credit: Getty Images. The expanded approval was based on pediatric extrapolation of efficacy from adequate and well-controlled studies and pharmacokinetic data in adult heart transplant and liver ...

Shares of Aspreva Pharmaceuticals Corp. sank to a new 52-week low on Wednesday after the company disclosed that the induction portion of a Phase III clinical trial of CellCept (oral mycophenolate ...

Aspreva Pharmaceuticals Corp says that regulators in the USA have granted fast-track designation to CellCept, the Roche immunosuppressant that the Canadian firm is developing as a treatment for the ...

CellCept (mycophenolate mofetil) is a brand-name drug that’s prescribed to help prevent organ rejection after a transplant in adults and some children. CellCept comes in several forms. The dosage can ...